Amarin Corp Plcuk (AMRN) Operating Income (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Operating Income of -$12.0 million for Q2 2026, up 24.87% year-over-year from -$9.6 million in Q2 2025, and down 5.96% quarter-over-quarter from -$11.3 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Operating Income (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Operating Income for 17 consecutive years, with -$12.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Income rose 24.87% year-over-year to -$12.0 million; the TTM figure through Jun 2026 stood at -$40.8 million (up 63.08% YoY), while the FY2025 annual figure was -$50.2 million, up 45.35% from the prior year.
- Operating Income eased to -$12.0 million in Q2 2026 per AMRN's latest filing, from -$11.3 million in the prior quarter.
- Across five years, Operating Income topped out at -$524000.0 in Q2 2024 and bottomed at -$62.8 million in Q2 2022.
- Historically, Operating Income has averaged -$18.8 million across 5 years, with a median of -$14.8 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Income soared 97.81% — and 2025, when it tumbled 2950.57%.
- Amarin Corp Plc\Uk's Operating Income stood at -$9.6 million in 2022, then soared by 49.54% to -$4.8 million in 2023, then plunged by 985.84% to -$52.5 million in 2024, then jumped by 87.96% to -$6.3 million in 2025, then plunged by 89.88% to -$12.0 million in 2026.
- Business Quant data shows AMRN's Operating Income at -$12.0 million in Q2 2026, -$11.3 million in Q1 2026, and -$6.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 645.35 Mn |
| 10 | Amarin Corp Plcuk | 5.88 Bn | 5.56 Bn | 14.99 Mn | -12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.01 Mn |
| Mar 31, 2026 | -11.33 Mn |
| Dec 31, 2025 | -6.33 Mn |
| Sep 30, 2025 | -11.10 Mn |
| Jun 30, 2025 | -15.99 Mn |
| Mar 31, 2025 | -16.76 Mn |
| Dec 31, 2024 | -52.52 Mn |
| Sep 30, 2024 | -25.17 Mn |
| Jun 30, 2024 | -524,000.00 |
| Mar 31, 2024 | -13.58 Mn |
| Dec 31, 2023 | -4.84 Mn |
| Sep 30, 2023 | -21.45 Mn |
| Jun 30, 2023 | -23.96 Mn |
| Mar 31, 2023 | -17.34 Mn |
| Dec 31, 2022 | -9.59 Mn |
| Sep 30, 2022 | -5.14 Mn |
| Jun 30, 2022 | -62.83 Mn |
| Mar 31, 2022 | -28.31 Mn |
| Dec 31, 2021 | 16.13 Mn |
| Sep 30, 2021 | -13.07 Mn |